Bhatia selected as Mass-High-Tech 2009 "Women to Watch"

January 28, 2009

Electrical Engineering and Computer Science and Health Sciences and Technology Professor, Sangeeta N. Bhatia, was named one of the 10 "Women to Watch" on Jan. 23 by the online publication Mass High Tech: the Journal of New England Technology.

Also a member of the David H. Koch Institute for Integrative Cancer Research at MIT and a Howard Hughes Medical Investigator, Bhatia will be recognized by the Mass-High-Tech at a gala event on Thursday, March 12, along with the nine others who were cited for outstanding dedication to technology, entrepreneurship, lifelong learning and civic responsibility. The selection of the 2009 honorees was made by members of Mass-High-Tech working with an advisory panel drawn from some of the region’s leading academic and business institutions.

Sangeeta Bhatia's research in the Laboratory for Multiscale Regenerative Technologies is focused on the applications of micro- and nanotechnology to tissue repair and regeneration.

Specifically, she studies the interactions between hepatocytes (liver cells) and their microenvironment and develops microfabrication tools to improve cellular therapies for liver disease (Hepatic Tissue Engineering).

She is also interested in using arrays of living cells as high-throughput platforms to study fundamental aspects of stem cell biology (Cell-Based BioMEMS) using a diverse repertoire of tools including chemical, topological, fluidic, electrical, and optical manipulation of living cells on chip platforms.

Bhatia is also working with a multidisciplinary team to develop nanomaterials as tools for biological studies and as multifunctional agents for cancer therapies. Interests center around nanoparticles and nanoporous materials that can be designed to perform complex tasks such as: home to a tumor, sense changes in cells and tissues, enhance imaging, and trigger the release of a therapeutic payload.

Having had several stints in the biotechnology industry, Dr. Bhatia holds a number of patents for both clinical and biotechnological applications of engineering principles. She is the author of Microfabrication in Tissue Engineering and Bioartificial Organs and co-author of the undergraduate textbook Tissue Engineering. And, based on her engineering for miniature micro liver cells, Bhatia co-founded (with HST colleague Salman Khetani) a company called Hepregen in 2008.

Congratulations Sangeeta!